Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Mar
25
2019
Ned Sharpless Named New Acting FDA Commissioner Keller and Heckman LLP
Mar
30
2022
FDA Requests $8.4 Billion to Further Public Health Efforts Keller and Heckman LLP
May
2
2022
New Draft Guidance on FDA’s Accredited Third-Party Certification Program Keller and Heckman LLP
May
9
2022
Continuing Litigation of California’s Foie Gras Ban Keller and Heckman LLP
May
1
2019
FDA Announces “New Era of Smarter Food Safety” Keller and Heckman LLP
May
23
2022
New Draft Guidance on FDA Enforcement Discretion for Past-Due NDI Notifications Keller and Heckman LLP
May
13
2019
FDA’s Quiet Reorganization of the Office of Food Additive Safety Begins Today Keller and Heckman LLP
Jun
10
2022
Class Action Complaint filed in Eastern District of New York challenging “Natural” Dietary Supplements Keller and Heckman LLP
Jun
15
2022
Beyond Meat Sued Over Protein Content Claims Keller and Heckman LLP
Jun
23
2022
U.S. Government Files Amicus Brief in Prop 12 Case Keller and Heckman LLP
Jun
10
2019
FDA Forms PFAS Working Group Keller and Heckman LLP
Jul
12
2022
FDA to Develop Framework for Continued Expanded Access to Infant Formula Keller and Heckman LLP
Jul
15
2022
Gerber Argues FDA Preemption in Baby Food Lawsuit Keller and Heckman LLP
Jun
26
2019
FDA Issues Warning Letters to Companies Illegally Selling Unapproved, Misbranded Kratom Products Keller and Heckman LLP
Aug
2
2022
FDA Finalizes NAC Enforcement Discretion Guidance Keller and Heckman LLP
Jul
1
2019
FDA Adds 20 New Substances to its Inventory of Effective FCS Notifications Keller and Heckman LLP
Aug
8
2022
Data on Toxic Elements from FDA’s July 2022 Total Diet Study Report Keller and Heckman LLP
Aug
16
2022
Lawsuit Alleges Plant Butter Deceptively Labeled Keller and Heckman LLP
Jul
9
2019
EU to Increase Transparency of Risk Assessments in the Food Chain Keller and Heckman LLP
Aug
19
2022
Food and Chemicals Unpacked: Got Milk? An Inside Look at the Infant Formula Shortage [PODCAST] Keller and Heckman LLP
Jul
12
2019
How Are Vegetarian Foods Labeled in India? Keller and Heckman LLP
Aug
25
2022
FDA Publishes 2022 Retail Food Program Standards Keller and Heckman LLP
Aug
30
2022
Canada Establishes New Maximum Levels for Arsenic in Certain Foods Keller and Heckman LLP
Sep
13
2022
Feedback Sought on Regulation of Inert Ingredients in Pesticides for Organic Production Keller and Heckman LLP
Sep
20
2022
“Made with Real Butter” Claim Challenged Keller and Heckman LLP
Aug
6
2019
Congress Continues Efforts to Combat Food Waste Keller and Heckman LLP
Aug
20
2019
USDA No Longer Requires Pet Food to be Manufactured During Hours of Inspectional Supervision Keller and Heckman LLP
Oct
11
2022
Court Rejects Challenge to USDA’s New Swine Slaughter Inspection Rule Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins